Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Training Program in Nervous System Tumors
Imaging Studies in Neurotoxicity and Neurodevelopment
MLSCN Center at Columbia University
Impact of gender differences in morphine metabolites.
Analysis of Cell Transformation by Retrovirus
Recently added grants:
Mechanisms regulating the aging of HSC niches
Molecular Regulation of Hepatocyte Proliferation and Liver Regeneration
The interleukin-1 receptor regulates crosstalk between myeloid and renal tubular cells in hypertension
Molecular Mechanisms of Cholestatic Fibrogenesis
SMPDL3b and podocyte insulin signaling in DKD
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07150-16-0-1
Application #
7574909
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ Children's Research Institute
$441,961
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
Minniti, Caterina /
$653,568
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant